Pelthos Therapeutics Inc. Transfer from Investments
Pelthos Therapeutics Inc. (PTHS) reported Transfer from Investments of $2.15 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:TransferOfInvestments · last filed 2025-11-13
- Pelthos Therapeutics Inc. transfer from investments for the quarter ending 2024-12-31 was $362.00.
- Pelthos Therapeutics Inc. transfer from investments for the quarter ending 2024-09-30 was -$362.00.
- Pelthos Therapeutics Inc. transfer from investments for the quarter ending 2024-06-30 was $0.00.
- Pelthos Therapeutics Inc. transfer from investments for the quarter ending 2024-03-31 was $2.15M.
- Pelthos Therapeutics Inc. transfer from investments for fiscal 2024 was $2.15M.
| Period end | Transfer from Investments 3 month | Transfer from Investments 6 month | Transfer from Investments 9 month | Transfer from Investments 9 month as first filed | Transfer from Investments 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $362.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 derived: sum of 3 quarters · filed 2025-11-13 | $2.15M 10-K · filed 2025-03-27 | |
| 2024-09-30 | -$362.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$362.00 derived: sum of 2 quarters · filed 2025-11-13 | $2.15M 10-Q · filed 2025-11-13 | $2.15M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $2.15M 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | $2.15M 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |